We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.04%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$1.2B
AUM Growth
-$33.6M
(-2.7%)
Cap. Flow
+$15.8M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
22.6%
Holding
147
New
20
Increased
35
Reduced
44
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$37.2M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$24.3M |
| 3 |
Health Catalyst
HCAT
|
+$24.1M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
+$22.2M |
| 5 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$21.8M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
+$21.4M |
| 3 |
Repligen
RGEN
|
+$20M |
| 4 |
OSH
Oak Street Health, Inc.
OSH
|
+$18.8M |
| 5 |
NEUE
NeueHealth
NEUE
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 94.67% |
| 2 | Industrials | 4.36% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFTR
1
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $40.5M | 3.37% |
+115,310
| New | +$37.2M |
|
2
Evolent Health
EVH
$667M
| $32.1M | 2.67% |
1,036,638
-437,500
| -30% | -$10.5M |
|
|
SYNH
3
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $27.6M | 2.3% |
315,606
+44,400
| +16% | +$4.02M |
|
4
Arcus Biosciences
RCUS
$3.54B
| $25.8M | 2.14% |
739,010
+64,750
| +10% | +$2.02M |
|
5
Arvinas
ARVN
$517M
| $25.3M | 2.11% |
308,392
+25,600
| +9% | +$2.26M |
|
|
RCM
6
DELISTED
R1 RCM Inc. Common Stock
RCM
| $25M | 2.08% |
1,136,089
+500
| +0% | +$10.3K |
|
7
Insmed
INSM
$23.2B
| $24.5M | 2.04% |
888,700
-25,000
| -3% | -$656K |
|
8
AtriCure
ATRC
$1.76B
| $24.1M | 2% |
346,017
-30,550
| -8% | -$2.35M |
|
|
NARI
9
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $23.5M | 1.95% |
+289,650
| New | +$24.3M |
|
|
SILK
10
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $23.4M | 1.94% |
+424,500
| New | +$22.2M |
|
|
FOLD
11
DELISTED
Amicus Therapeutics
FOLD
| $23M | 1.91% |
2,410,604
+319,200
| +15% | +$3.27M |
|
12
BridgeBio Pharma
BBIO
$15.8B
| $22.2M | 1.84% |
472,950
+147,100
| +45% | +$7.88M |
|
|
13
Health Catalyst
HCAT
$160M
| $22.1M | 1.83% |
+441,000
| New | +$24.1M |
|
|
ARNA
14
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $21.9M | 1.82% |
368,399
+45,800
| +14% | +$2.71M |
|
|
OCDX
15
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $20.7M | 1.72% |
1,118,170
-168,580
| -13% | -$3.39M |
|
16
Agilent Technologies
A
$36.8B
| $18.8M | 1.56% |
119,100
-27,100
| -19% | -$4.38M |
|
|
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $18.7M | 1.56% |
170,725
| – | – |
|
|
AGTI
18
DELISTED
Agiliti Inc
AGTI
| $18.6M | 1.55% |
977,269
+148,900
| +18% | +$3M |
|
19
Novavax
NVAX
$1.3B
| $18.5M | 1.54% |
89,450
+1,000
| +1% | +$220K |
|
20
Arcutis Biotherapeutics
ARQT
$3.44B
| $18.1M | 1.51% |
758,763
| – | – |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| $16.7M | 1.39% |
98,106
+29,750
| +44% | +$4.63M |
|
22
ResMed
RMD
$28.8B
| $15.8M | 1.32% |
60,105
-5,000
| -8% | -$1.37M |
|
23
Rocket Pharmaceuticals
RCKT
$375M
| $15.1M | 1.26% |
506,085
+35,950
| +8% | +$1.31M |
|
|
CNVY
24
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $14.6M | 1.22% |
1,739,870
-10,130
| -0.6% | -$90.2K |
|
25
Treace Medical Concepts
TMCI
$274M
| $14.6M | 1.21% |
541,022
+300,257
| +125% | +$8.26M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q3 2021 Portfolio in Review
As of Q3 2021, Sectoral Asset Management held 147 positions worth $1.2B, down 2.7% from $1.24B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Sectoral Asset Management's Q3 2021 filing shows 20 new, 35 increased, 44 reduced and 20 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M. The largest sale was Teleflex, an estimated $21.8M.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 94% a quarter earlier, followed by Industrials and Financials.
- Sectoral Asset Management's largest Q3 2021 buy was eFFECTOR Therapeutics, Inc. Common Stock: 115,310 shares worth $40.5M.
- Sectoral Asset Management added most to Treace Medical Concepts in Q3 2021, an estimated $8.26M increase.
- Sectoral Asset Management's biggest Q3 2021 reduction was Teleflex, cutting an estimated $21.8M.
- Sectoral Asset Management fully exited Oak Street Health, Inc. in Q3 2021, selling an estimated $18.8M.
- Sectoral Asset Management's ten largest holdings make up 23% of its $1.2B portfolio in Q3 2021.
- Sectoral Asset Management opened 20 new positions and closed 20 in Q3 2021.
- Sectoral Asset Management's portfolio value fell 2.7% quarter-over-quarter to $1.2B.
Based on Sectoral Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.